SUBSCRIBE
SUBSCRIBE

Gotham Therapeutics

NEWS
Business
Top Life Sciences Startups to Watch in 2020
BioSpace is proud to present its NextGen Bio “Class of 2020,” a list of up-and-coming life science companies in North America that launched no earlier than mid-2018.
January 3, 2020
 · 
13 min read
 · 
Mark Terry
Business
Gotham Therapeutics Launches in New York City with $54 Million Series A Financing
Gotham Therapeutics launched in New York with a $54 million Series A financing. The focus is on a subgroup of RNA metabolism called epitranscriptomics. This involves the biochemical modifications of RNA within a cell, which have an impact on gene expression.
October 10, 2018
 · 
2 min read
 · 
Mark Terry
IN THE PRESS
Business
Gotham Therapeutics Establishes Advanced Oncology Profiling Cascade with ProQinase to Progress its Portfolio of Epitranscriptomic Drug Candidates
October 29, 2019
 · 
3 min read
Pharm Country
Gotham Therapeutics and Mercachem Announce Progress in Compound Library Development Tailored for Epitranscriptomic Drug Discovery
July 17, 2019
 · 
3 min read
Business
Gotham Therapeutics and ZoBio Achieve Significant Milestone in Epitranscriptomic Drug Discovery Collaboration
May 21, 2019
 · 
4 min read
Business
Gotham Therapeutics Strengthens Board of Directors and Scientific Advisory Board
February 14, 2019
 · 
5 min read
AWARDS
  • NextGen Class of 2020
JOBS